SCHEMBL12476702

SCHEMBL12476702

C=CCc1cccc2c(OC)ncc(C=O)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
MAPT P10636 5/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
KMT2A Q03164 3/20 0.34
HTT P42858 3/20 0.34
MEN1 O00255 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAPK1 P28482 2/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
POLB P06746 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12476812 0.81 CD274 (0.36) ALDH1A1KDM4EADRA2AADRA2BADRA2C
SCHEMBL12476201 0.78 TRIM24 (0.40) ALDH1A1KDM4EKMT2ACYP1A2CYP2C19
SCHEMBL21267856 0.76 KMT2A (0.39) ALDH1A1MAPTTDP1KDM4ESMN1; SMN2
SCHEMBL24968896 0.75 ALDH1A1 (0.44) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL22094077 0.73 ALDH1A1 (0.48) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL7135448 0.70 CA1 (0.53) ALDH1A1MAPTTDP1KDM4ESMN1; SMN2
SCHEMBL31130510 0.70 CA1 (0.53) ALDH1A1MAPTTDP1KDM4ESMN1; SMN2
SCHEMBL14064716 0.68 KMT2A (0.47) MAPTTDP1SMN1; SMN2KMT2AMEN1
SCHEMBL4806977 0.65 CA1 (0.40) MAPTKDM4EKMT2AMEN1L3MBTL1
SCHEMBL22360135 0.65 ALDH1A1 (0.41) ALDH1A1MAPTKDM4ESMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006442-B2 Cannabinoid receptor modulators LUPIN LIMITED (IN) 2015-04-14 US disclosed
US-20130178457-A1 CANNABINOID RECEPTOR MODULATORS LUPIN LIMITED (IN) 2013-07-11 US disclosed
WO-2013005168-A2 CANNABINOID RECEPTOR MODULATORS LUPIN LIMITED (IN) 2013-01-10 WO disclosed
WO-2012090177-A2 CANNABINOID RECEPTOR MODULATORS LUPIN LIMITED (IN) 2012-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178457-A1 CANNABINOID RECEPTOR MODULATORS CNR1, CNR2, GPR18 ALDH1A1 1861/4885MAPT 2605/4885TDP1 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.